Asclera

Asclera® (pronounced a skler ah) is an injectable administered by Dr. Rogers and qualified members of his staff to treat varicose veins, spider veins, and reticular veins.  The procedure during which the injectable is administered is called sclerotherapy.

Highlights

Asclera® is a sclerosing agent that is injected into the vein. It works by damaging the endothelium, the cells lining the inside of blood vessels. This causes blood platelets to attach to the lining of the vessels; eventually, cellular debris and platelets cause the blood vessel to clot. Over time, the clotted vein will be replaced with tissue.

  • Get rid of the unsightly vericose veins
  • Quick 30 minute treatment
  • Minimal recovery
  • FDA approved

Candidates

Candidates for sclerotherapy with Asclera are individuals with uncomplicated spider veins (very small varicose veins ≤ 1 mm in diameter), as well as those with uncomplicated small varicose veins (1 to 3 mm in diameter) known as reticular veins.  Below are some general descriptions of each of these types of unsightly veins:

  • Varicose veins

Varicose veins are large blue, dark purple veins. They protrude from the skin and many times they have a cord-like appearance and may twist or bulge. Varicose veins are found most frequently on the legs.

  • Spider Veins

Spider veins are very small and very fine red or blue veins. They are closer to the surface of the skin than varicose veins. They can look like a thin red line, tree branches or spider webs. Spider veins can be found on the legs and face and may cover a small or large area.

  • Reticular veins

Reticular veins can also be known as feeder veins. They are the blue and green veins beneath the surface of the skin.  Reticular veins enlarge because of increased pressure in the vein. They can be caused by heredity. You may have reticular veins alone but you may also have spider veins at the same time.

Treatment

A typical sclerotherapy session lasts 15 to 45 minutes. One injection is usually administered per inch with multiple injections per session. Following treatment compression stockings or support hose should be worn continuously for 2-3 days and for 2-3 weeks during the day time.

Results

In an independent study conducted by Asclera, an average of 86% of patients were satisfied or very satisfied with their treatment.  Patients were also significantly more satisfied with Asclera® than with either sodium tetradecyl sulfate (STS) or placebo (p<0.0001).

 

Comments are closed.